MetLife Investment Management’s NuScale Power SMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$945K Buy
87,164
+14,977
+21% +$228K ﹤0.01% 1422
2025
Q4
$1.02M Sell
72,187
-1,957
-3% -$56K ﹤0.01% 1418
2025
Q3
$2.67M Sell
74,144
-1,584
-2% -$63.1K 0.01% 948
2025
Q2
$3M Buy
75,728
+22,628
+43% +$568K 0.02% 799
2025
Q1
$752K Buy
53,100
+1,822
+4% +$36.8K ﹤0.01% 1506
2024
Q4
$919K Buy
51,278
+5,915
+13% +$122K 0.01% 1457
2024
Q3
$525K Hold
45,363
﹤0.01% 1757
2024
Q2
$530K Buy
45,363
+16,006
+55% +$114K ﹤0.01% 1691
2024
Q1
$156K Buy
29,357
+335
+1% +$1.2K ﹤0.01% 2327
2023
Q4
$95.5K Hold
29,022
﹤0.01% 2628
2023
Q3
$142K Hold
29,022
﹤0.01% 2395
2023
Q2
$197K Buy
29,022
+10,621
+58% +$86.2K ﹤0.01% 2283
2023
Q1
$167K Hold
18,401
﹤0.01% 2326
2022
Q4
$189K Hold
18,401
﹤0.01% 2281
2022
Q3
$215K Buy
+18,401
New +$242K ﹤0.01% 2254

Other funds holding SMR

MetLife Investment Management's SMR Position: Q1 2026 in Review

MetLife Investment Management increased its NuScale Power (SMR) stake by 21% in Q1 2026, buying an estimated $228K and bringing the position to 87,164 shares worth $945K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

MetLife Investment Management first reported a position in SMR in Q3 2022 and has held it in 15 quarters since. The position peaked at $3M in Q2 2025. 493 funds tracked by Wall St. Rank hold SMR as of Q1 2026.

  • MetLife Investment Management held 87,164 shares of NuScale Power worth $945K as of Q1 2026.
  • MetLife Investment Management bought 14,977 NuScale Power shares in Q1 2026, an estimated $228K.
  • NuScale Power made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1422 holding.
  • MetLife Investment Management first reported a position in NuScale Power in Q3 2022 and has held it in 15 quarters since.
  • MetLife Investment Management's NuScale Power position peaked at $3M in Q2 2025.
  • 493 funds tracked by Wall St. Rank held NuScale Power as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.